Directory

>

Greg Oehrtman

avatar

Greg Oehrtman

Scientist, Formulation Development Oral Solids | AVEO Oncology

Massachusetts, Boston, United States

View contact details (it's free)

Greg Oehrtman

Summary

Greg Oehrtman is an accomplished leader in the pharmaceutical and biotechnology sectors, currently serving as the VP of Technical Operations at Aveo Oncology. With extensive experience in formulation development and clinical/commercial supply logistics, he has successfully overseen the development of injectable and oral dosage forms for various oncology products. His career spans multiple prestigious organizations where he has led cross-functional teams in the development of innovative drug delivery systems, including reusable injection pens and controlled-release formulations. Greg holds a Ph.D. in Chemical Engineering from MIT, where he focused on bioengineered systems and receptor-ligand interactions. He has a proven track record in regulatory submissions and has authored numerous CMC sections for IND and NDA filings. Beyond his technical expertise, Greg is known for his strategic vision and ability to manage complex projects effectively, driving commercialization efforts from concept to market launch.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Greg Oehrtman

Work Experience

company logo

VP of Technical Operations at

AVEO Oncology

August 2022 - Present

Logos provided by Logo.dev

Greg Oehrtman

Education

Massachusetts Institute of Technology, Ph.D., Chemical Engineering

The University of Texas at Austin, BS, Chemical Engineering

University of Illinois Urbana-Champaign, MS, Chemical Engineering

Frequently Asked Questions about Greg Oehrtman

What is Greg Oehrtman email address?

Greg Oehrtman's primary email address is *************@quintiles.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Greg Oehrtman work for?

Greg Oehrtman is a Scientist, Formulation Development Oral Solids at AVEO Oncology.

Where Greg Oehrtman graduated from?

Greg Oehrtman holds a degree in Ph.D. Thesis: Quantification of Receptor – Ligand Interactions on Bioengineered Autocrine Cell System – A Comparison on Theory and Experiments Refined an autocrine / antibody inhibitor mathematical model. Developed phosphotyrosine and EGFR ELISAs, and TGFa assays (RIA, RT-PCR / RPA). Developed novel method for quantifying autocrine complexes using Molecular Devices Cytosensor. Advisors: Douglas A. Lauffenburger, MIT, Dept. of Chemical Engineering and H. Steven Wiley, Univ. of Utah – Dept. of Cell Biology Show less from Massachusetts Institute of Technology.

How can I directly contact Greg Oehrtman?

To contact Greg Oehrtman directly, you can use the email address *************@quintiles.com. Complete contact information is available upon registration with Muraena.

Who is Greg Oehrtman?

Greg Oehrtman is an accomplished leader in the pharmaceutical and biotechnology sectors, currently serving as the VP of Technical Operations at Aveo Oncology. With extensive experience in formulation development and clinical/commercial supply logistics, he has successfully overseen the development of injectable and oral dosage forms for various oncology products. His career spans multiple prestigious organizations where he has led cross-functional teams in the development of innovative drug delivery systems, including reusable injection pens and controlled-release formulations. Greg holds a Ph.D. in Chemical Engineering from MIT, where he focused on bioengineered systems and receptor-ligand interactions. He has a proven track record in regulatory submissions and has authored numerous CMC sections for IND and NDA filings. Beyond his technical expertise, Greg is known for his strategic vision and ability to manage complex projects effectively, driving commercialization efforts from concept to market launch.

Greg`s contact details

mail

*************@quintiles.com

*************@stealthpeptides.com

*************@stealthbt.com

*********@aveooncology.com

Colleagues

avatar
Kevin Peacock

Conversion Manager

avatar
Danielle V Holland

Corps Member/Elementary Special Education Teacher

avatar
Mike Ferraresso

Sales Analyst

avatar
Michael Mcdole

Director of National Accounts

avatar
David Crist

Regional Business Director

avatar
Emile Farhan

Director, Chemical Development

John Ryan

VP of Clinical Development

View Contact details (it's free)
Request Profile Removal